AstraZeneca's Crestor reduces risk of blood clots in the veins - A new analysis from the JUPITER study shows that CRESTOR® (rosuvastatin calcium) 20mg significantly cut the risk of venous …
Today’s Top Three in Pharma 022009
Genentech's Raptiva: Trouble - The FDA said today that patients taking the Genentech drug Raptiva are at risk of developing a potentially fatal condition known as PML, or progressive multifocal …
Pharma News this week
Some surprises in the new diabetes guidelines issue by the American Diabetes Association and European Association for the Study of Diabetes...more Speaking of diabetes - we're paying a lot more over …
Pharma News 10_10
J&J announces leadership transition - Johnson & Johnson appointed Sheri McCoy, leader of its surgical care group, on Thursday worldwide chairman of its pharmaceuticals group, effective Jan. 1. …
August ’08 Pharma News
The Xa factor: not looking so promising for Pfizer and Bristol - Bristol-Myers Squibb and Pfizer's apixaban blood clot preventer raised rates of bleeding in a 6-month study but showed some encouraging …
Pharma News 6_6
Fresh news from the ADA (American Diabetes Association): Takeda's alogliptin shows impressive results - Takeda Pharmaceutical Co Ltd's experimental diabetes drug alogliptin significantly lowers …